Wright D T, Cohn L A, Li H, Fischer B, Li C M, Adler K B
Department of Anatomy, Physiological Sciences, and Radiology, North Carolina State University, College of Veterinary Medicine, Raleigh 27606.
Environ Health Perspect. 1994 Dec;102 Suppl 10(Suppl 10):85-90. doi: 10.1289/ehp.94102s1085.
Reactive oxygen species (ROS) have been implicated in the pathogenesis of numerous disease processes. Epithelial cells lining the respiratory airways are uniquely vulnerable regarding potential for oxidative damage due to their potential for exposure to both endogenous (e.g., mitochondrial respiration, phagocytic respiratory burst, cellular oxidases) and exogenous (e.g., air pollutants, xenobiotics, catalase negative organisms) oxidants. Airway epithelial cells use several nonenzymatic and enzymatic antioxidant mechanisms to protect against oxidative insult. Nonenzymatic defenses include certain vitamins and low molecular weight compounds such as thiols. The enzymes superoxide dismutase, catalase, and glutatione peroxidase are major sources of antioxidant protection. Other materials associated with airway epithelium such as mucus, epithelial lining fluid, and even the basement membrane/extracellular matrix may have protective actions as well. When the normal balance between oxidants and antioxidants is upset, oxidant stress ensues and subsequent epithelial cell alterations or damage may be a critical component in the pathogenesis of several respiratory diseases. Oxidant stress may profoundly alter lung physiology including pulmonary function (e.g., forced expiratory volumes, flow rates, and maximal inspiratory capacity), mucociliary activity, and airway reactivity. ROS may induce airway inflammation; the inflammatory process may serve as an additional source of ROS in airways and provoke the pathophysiologic responses described. On a more fundamental level, cellular mechanisms in the pathogenesis of ROS may involve activation of intracellular signaling enzymes including phospholipases and protein kinases stimulating the release of inflammatory lipids and cytokines. Respiratory epithelium may be intimately involved in defense against, and pathophysiologic changes invoked by, ROS.
活性氧(ROS)与众多疾病进程的发病机制有关。呼吸道内衬的上皮细胞因有可能接触内源性(如线粒体呼吸、吞噬细胞呼吸爆发、细胞氧化酶)和外源性(如空气污染物、异生物素、过氧化氢酶阴性生物体)氧化剂,在遭受氧化损伤方面格外脆弱。气道上皮细胞利用多种非酶促和酶促抗氧化机制来抵御氧化损伤。非酶促防御包括某些维生素和低分子量化合物,如硫醇。超氧化物歧化酶、过氧化氢酶和谷胱甘肽过氧化物酶是抗氧化保护的主要来源。与气道上皮相关的其他物质,如黏液、上皮衬液,甚至基底膜/细胞外基质也可能具有保护作用。当氧化剂和抗氧化剂之间的正常平衡被打破时,就会产生氧化应激,随后上皮细胞的改变或损伤可能是几种呼吸道疾病发病机制中的关键组成部分。氧化应激可能会深刻改变肺生理功能,包括肺功能(如用力呼气量、流速和最大吸气量)、黏液纤毛活动和气道反应性。ROS可能会引发气道炎症;炎症过程可能会成为气道中ROS的额外来源,并引发上述病理生理反应。在更基本的层面上,ROS发病机制中的细胞机制可能涉及细胞内信号酶的激活,包括磷脂酶和蛋白激酶,刺激炎症脂质和细胞因子的释放。呼吸道上皮可能密切参与对ROS的防御以及由ROS引发的病理生理变化。